Open AccessThe Study of Nanomicellar Daunorubicin for AML Treatment
Author(s) -
Richard Simoneaux
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000581700.56632.fb
Subject(s) - daunorubicin , myeloid leukemia , cytarabine , leukemia , medicine , chemotherapy , regimen , pharmacology , oncology , chemotherapy regimen , cancer research , immunology